Stay updated on LN-145 & Durvalumab Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No significant changes detected between the old and new screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T20:48:22.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T04:51:04.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Updated software version from v3.0.2 to v3.1.0, reflecting a new release without other substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-29T02:56:35.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; no substantive changes to core content detected. Removal of 'Back to Top' is a minor UI change.
    Difference
    0.3%
    Check dated 2025-09-14T18:51:44.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-09-07T13:36:31.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new drug information for Lifileucel and details on various receptors. However, it has also removed specific location details and previous drug information for Durvalumab.
    Difference
    4%
    Check dated 2025-08-31T11:34:54.000Z thumbnail image

Stay in the know with updates to LN-145 & Durvalumab Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.